Bukit Sembawang Estates Limited (SGX:B61)

Verve Therapeutics Balance Sheet

Financials in millions SGD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	582.42	452.24	294.01	530.11	728.97
Short-Term Investments	0.97	0.9	0.89	1.23	0.74
Cash & Short-Term Investments	583.39	453.14	294.9	531.34	729.71
Cash Growth	28.74%	53.66%	-44.50%	-27.18%	142.28%
Accounts Receivable	888.99	907.41	1,038	911.23	995.24
Other Receivables	0.74	2.07	0.99	0.4	0.64
Receivables	889.73	909.48	1,039	911.63	995.88
Prepaid Expenses	1.57	0.33	0.43	0.62	0.82
Other Current Assets	4.66	11.78	16.15	1.85	6.71
Total Current Assets	1,479	1,375	1,350	1,445	1,733
Property, Plant & Equipment	213.16	212.52	212.41	212.36	204.05
Long-Term Deferred Tax Assets	0.9	8.55	13.02	12.4	10.9
Other Long-Term Assets	2.67	2.84	3	3.16	3.32
Total Assets	1,696	1,599	1,579	1,673	1,951
Accounts Payable	3.76	11.27	4.37	1.25	2.23
Accrued Expenses	4.23	4.31	3.7	3.52	4.65
Current Portion of Long-Term Debt	-	-	24.98	-	-
Current Portion of Leases	0.54	0.42	0.5	0.48	0.37
Current Income Taxes Payable	2.48	1.27	3.41	19.31	37.26
Current Unearned Revenue	23.18	15.05	39.98	15.98	43.35
Other Current Liabilities	48.68	39.93	25.99	19.03	31.93
Total Current Liabilities	82.86	72.25	102.93	59.57	119.79
Long-Term Debt	-	-	-	130.86	337.86
Long-Term Leases	0.48	0.23	0.45	0.77	0.4
Long-Term Unearned Revenue	-	-	-	-	3.69
Long-Term Deferred Tax Liabilities	19.89	6.16	0.1	0.04	5.01
Other Long-Term Liabilities	0.09	0.09	0.15	0.15	0.15
Total Liabilities	103.31	78.73	103.62	191.38	466.89
Common Stock	631.8	631.8	631.8	631.8	631.8
Retained Earnings	960.98	888.12	843.16	850.18	852.71
Shareholders' Equity	1,593	1,520	1,475	1,482	1,485
Total Liabilities & Equity	1,696	1,599	1,579	1,673	1,951
Total Debt	1.01	0.65	25.93	132.11	338.63
Net Cash (Debt)	582.38	452.49	268.97	399.23	391.08
Net Cash Growth	28.71%	68.23%	-32.63%	2.08%	-
Net Cash Per Share	2.25	1.75	1.04	1.54	1.51
Filing Date Shares Outstanding	258.91	258.91	258.91	258.91	258.91
Total Common Shares Outstanding	258.91	258.91	258.91	258.91	258.91
Working Capital	1,396	1,302	1,247	1,386	1,613
Book Value Per Share	6.15	5.87	5.70	5.72	5.73
Tangible Book Value	1,593	1,520	1,475	1,482	1,485
Tangible Book Value Per Share	6.15	5.87	5.70	5.72	5.73
Machinery	29.78	29.68	29.6	29.52	29.45

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.